The Sartorius/BI Advanced Therapies Grant Program aims to support academic researchers developing hPSC, hMSC, or human immune cell research and applications that will help advance medical progress in the fields of regenerative medicine and cell-based therapies by offering full-scale serum- and xeno-free cell culture solutions.
Winners will receive:
- Up to $25,000 in state-of-the-art media and reagents
- Six (6) months of dedicated scientific support and technical consultation
To apply for a chance to win up to $25,000 in AT media and reagents and dedicated scientific support for up to six (6) months, please submit your proposal online and send any additional supporting materials to Oren.Ben-Yosef@Sartorius.com by June 30, 2021.
The application process is open to all U.S. citizens and legal residents who are at least 18 years old and performing research in cell-based therapies in the U.S. at the time of application. All proposals will be reviewed by Sartorius’s scientific leadership together with independent experts. Funding considerations are awarded for outstanding research performed by the applicant and in alignment with strategic focus areas.